Alphyn Biologics
Annapolis, MD
Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases. Alphyn's initial target indication are skin infections caused by deadly drug-resistant MRSA bacteria based on their proprietary Multi-Target Therapeutic (MTT) plant-derived technology platform.
alphynbiologics.comCompany Details
Founded
- 2019
Employees
- Between 2 - 10 employees
Raised
- $11,828,198
Headquarters Location
- Annapolis, MD
Public
- No
Acquired
- No
CEO
Neal Koller
Founders
- Neal Koller
Company Collections
These are collections Alphyn Biologics is a part of. Click on the collection name to view similar companies.